The Form 4 filing, an SEC report of insider stock activity, was filed on November 16, 2026. The trade took place on November 12, 2026. Richard R. DeLuca is an executive vice president and president of Merck Animal Health.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-12 |
| Date of Latest Transaction | 2026-11-12 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 58,185 |
| Price | $148.01 |
| Total Transaction Value | $8,611,874.57 |
| Insider | |
| Ticker Symbol | MRK |
| Company | Merck & Co., Inc. |
| Insider Name | DeLuca Richard R. |
| Insider Title | EVP&Pres, Merck Animal Heallth |
| Sector - Industry | Healthcare - Drug Manufacturers - General |
| Holdings | |
| Total Shares Owned After Transaction | 112,955.43 |
| Position Size Change | 34.00% |
| Filing | |
| Filing Date | 2026-11-16 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of MRK shares under transaction code S. It was also identified as linked to an exercise or conversion. Those steps can involve using a right to buy shares or exchanging another type of investment for shares.
What was the average price of the transaction?
The average sale price was $148.0085 per share, shown as $148.01 when rounded to cents.
How did this transaction affect the insider's holdings?
He sold 58,185 shares and reported 112,955.434 shares owned afterward, shown as 112,955.43 after rounding. The sale was 34.00% of the shares he owned before the sale.
What's the total transaction value?
The total sale value was $8,611,874.57 for one transaction. Before rounding to cents, the value was $8,611,874.5725.
Are there any special circumstances around this transaction?
The sale was identified as linked to a code M exercise or conversion with the same share count in the same filing. The other transaction entry and footnotes are not available here, so the link cannot be checked further.
Matching share counts alone do not confirm that the exact shares received were sold. They also do not show that both steps happened on the same day or that the sale paid taxes.
For research purposes only; not investment advice.